Search research articles
Contact Us
Filters
Showing results (1-10 of 128) with videos related to
Page
of 13
Sort By:
American Journal of Clinical Dermatology
|
February 15, 2021
Psoriasis in Patients with Metabolic Syndrome or Type 2 Diabetes Mellitus: Treatment Challenges
Sukhmani Pannu, David Rosmarin
American Journal of Clinical Dermatology
|
January 30, 2023
Vitiligo Treatments: Review of Current Therapeutic Modalities and JAK Inhibitors
Kaitlynne N Cunningham, David Rosmarin
The New England Journal of Medicine
|
August 11, 2006
Images in clinical medicine. Inguinal hernia
David Rosmarin, Chen S Tan
Journal of Drugs in Dermatology : JDD
|
May 19, 2005
The potential of interleukin 12 inhibition in the treatment of psoriasis
David Rosmarin, Bruce E Strober
The Journal of the American Academy of Psychiatry and the Law
|
December 14, 2021
The Boundaries of Critiquing a Colleague
Karen B Rosenbaum, David Rosmarin
The New England Journal of Medicine
|
July 10, 2024
Anti-Interleukin-23 Autoantibodies in Adult-Onset Immunodeficiency
David Rosmarin, Shivkar Amara, Mark Lebwohl
Journal of Drugs in Dermatology : JDD
|
August 10, 2022
Usage of Topical Calcineurin Inhibitors in the Medicare Population from 2013 to 2018
Christine Learned, Sara Alsukait, David Rosmarin
Journal of Drugs in Dermatology : JDD
|
December 5, 2022
A Potential Alternative Treatment for Vitiligo: An Observational Study on Tacrolimus 0.3% Lotion
Sandhya Deverapalli, Jared Kahn, David Rosmarin
The New England Journal of Medicine
|
January 18, 2023
Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo. Reply
David Rosmarin, Deanna Kornacki, Khaled Ezzedine
Journal of Drugs in Dermatology : JDD
|
April 7, 2023
Open-Label Phase 2 Pilot Study of Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythematosus (DLE)
Sarah Alsukait, Christine Learned, David Rosmarin
Page
of 13
Search research articles
Search
Showing results (1-10 of 128) with videos related to
Sort By:
Page
of 13
American Journal of Clinical Dermatology
|
February 15, 2021
Psoriasis in Patients with Metabolic Syndrome or Type 2 Diabetes Mellitus: Treatment Challenges
Sukhmani Pannu, David Rosmarin
American Journal of Clinical Dermatology
|
January 30, 2023
Vitiligo Treatments: Review of Current Therapeutic Modalities and JAK Inhibitors
Kaitlynne N Cunningham, David Rosmarin
The New England Journal of Medicine
|
August 11, 2006
Images in clinical medicine. Inguinal hernia
David Rosmarin, Chen S Tan
Journal of Drugs in Dermatology : JDD
|
May 19, 2005
The potential of interleukin 12 inhibition in the treatment of psoriasis
David Rosmarin, Bruce E Strober
The Journal of the American Academy of Psychiatry and the Law
|
December 14, 2021
The Boundaries of Critiquing a Colleague
Karen B Rosenbaum, David Rosmarin
The New England Journal of Medicine
|
July 10, 2024
Anti-Interleukin-23 Autoantibodies in Adult-Onset Immunodeficiency
David Rosmarin, Shivkar Amara, Mark Lebwohl
Journal of Drugs in Dermatology : JDD
|
August 10, 2022
Usage of Topical Calcineurin Inhibitors in the Medicare Population from 2013 to 2018
Christine Learned, Sara Alsukait, David Rosmarin
Journal of Drugs in Dermatology : JDD
|
December 5, 2022
A Potential Alternative Treatment for Vitiligo: An Observational Study on Tacrolimus 0.3% Lotion
Sandhya Deverapalli, Jared Kahn, David Rosmarin
The New England Journal of Medicine
|
January 18, 2023
Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo. Reply
David Rosmarin, Deanna Kornacki, Khaled Ezzedine
Journal of Drugs in Dermatology : JDD
|
April 7, 2023
Open-Label Phase 2 Pilot Study of Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythematosus (DLE)
Sarah Alsukait, Christine Learned, David Rosmarin
Page
of 13